Tashani Mohamed, Barasheed Osamah, Azeem Mohammad, Alfelali Mohammad, Badahdah Al-Mamoon, Bokhary Hamid, Almasri Nedal, Alshehri Jassir, Matbouly Ghassan, Kalantan Nadeen, Heron Leon, Ridda Iman, Haworth Elizabeth, Asghar Atif, Rashid Harunor, Booy Robert
National Centre for Immunisation, Research and Surveillance, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.
Infect Disord Drug Targets. 2014;14(2):117-24. doi: 10.2174/1871526514666140713154727.
The uptake of the pneumococcal vaccine is suboptimal in Australia and remains unknown among Australian Hajj pilgrims, many of whom are eligible because of age or underlying disease and at particular risk because of travel and activities at Hajj. Pneumococcal vaccination uptake was examined over three consecutive years (2011 to 2013) through anonymous self-administered cross sectional surveys among Australian pilgrims who assembled in Mina valley, Mecca, Saudi Arabia. Respectively, 158, 513 and 219 pilgrims were recruited in 2011, 2012 and 2013; their mean ages were 43.8 (SD±13), 43 (SD±13.5) and 42.6 (SD±12.3) years; males accounted for 67 (42.4%), 325 (63.4%) and 172 (78.5%). Pneumococcal vaccine uptake rates were 28.5% (45/158), 28.7% (147/513) and 14.2% (31/219); among the pilgrims with 'at risk' conditions the pneumococcal vaccine uptake rates were 15 (30.6%), 43 (45.3%) and 9 (29%) respectively. According to our surveys, the pneumococcal vaccine uptake among Australian pilgrims is low. Further research is needed to explore the reasons through a validated study.
肺炎球菌疫苗在澳大利亚的接种率不理想，而澳大利亚朝觐者中的接种情况仍不明朗，其中许多人因年龄或基础疾病符合接种条件，且由于朝觐期间的旅行和活动面临特殊风险。通过对在沙特阿拉伯麦加米纳山谷聚集的澳大利亚朝觐者进行连续三年（2011年至2013年）的匿名自填式横断面调查，研究了肺炎球菌疫苗的接种情况。2011年、2012年和2013年分别招募了158名、513名和219名朝觐者；他们的平均年龄分别为43.8岁（标准差±13）、43岁（标准差±13.5）和42.6岁（标准差±12.3）；男性分别占67名（42.4%）、325名（63.4%）和172名（78.5%）。肺炎球菌疫苗接种率分别为28.5%（45/158）、28.7%（147/513）和14.2%（31/219）；在有“风险”状况的朝觐者中，肺炎球菌疫苗接种率分别为15名（30.6%）、43名（45.3%）和9名（29%）。根据我们的调查，澳大利亚朝觐者中肺炎球菌疫苗的接种率较低。需要通过一项经过验证的研究进一步探索原因。
